1. Home
  2. GRBK vs TLX Comparison

GRBK vs TLX Comparison

Compare GRBK & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Brick Partners Inc.

GRBK

Green Brick Partners Inc.

HOLD

Current Price

$66.33

Market Cap

3.5B

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$12.61

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRBK
TLX
Founded
N/A
2015
Country
United States
Australia
Employees
620
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.9B
IPO Year
2006
2024

Fundamental Metrics

Financial Performance
Metric
GRBK
TLX
Price
$66.33
$12.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$71.00
$21.13
AVG Volume (30 Days)
347.0K
291.8K
Earning Date
04-29-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.09
N/A
Revenue
$2,098,471,000.00
N/A
Revenue This Year
$0.07
N/A
Revenue Next Year
$10.33
N/A
P/E Ratio
$21.62
$150.33
Revenue Growth
N/A
N/A
52 Week Low
$60.44
$6.28
52 Week High
$83.18
$13.11

Technical Indicators

Market Signals
Indicator
GRBK
TLX
Relative Strength Index (RSI) 35.60 58.13
Support Level $64.49 $11.00
Resistance Level $74.15 N/A
Average True Range (ATR) 1.85 0.36
MACD -0.43 0.07
Stochastic Oscillator 11.05 79.88

Price Performance

Historical Comparison
GRBK
TLX

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment, which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgages and title.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: